Navigation Links
Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
Date:9/4/2007

SAN DIEGO, Sept. 4 /PRNewswire/ -- Takeda San Diego announced today that Keith Wilson, Ph.D. has been named president and chief scientific officer (CSO). In this position, he is responsible for overseeing all activities related to Takeda San Diego, Takeda Pharmaceutical Company Limited's U.S.-based drug discovery company.

"Dr. Wilson has been an important part of Takeda San Diego for several years and brings a wealth of scientific excellence to Takeda," said Shigenori Ohkawa, Ph.D., general manager, pharmaceutical research division, Takeda Pharmaceutical Company Limited. "His leadership has been instrumental in focusing the company on drug discovery and building the Takeda San Diego pipeline, and we look forward to his vital contributions in this new role."

Before being named president and CSO at Takeda San Diego, Dr. Wilson served dual roles as vice president of structural biology and vice president of business development. Prior to joining Takeda, he also spent a decade with Vertex Pharmaceuticals co-leading drug discovery programs and significant alliance projects.

Dr. Wilson has formal training in protein X-ray crystallography, and has a doctorate degree in physics from the University of Oregon and a bachelor's degree in physics from Colby College, where he graduated magna cum laude and was awarded the William A. Rogers prize in physics. Dr. Wilson is a contributing author on more than 30 peer-reviewed publications and co-inventor of six issued U.S. patents covering multiple drug candidates.

About Takeda San Diego, Inc.

Takeda San Diego is Takeda's first U.S.-based discovery research operation. Takeda San Diego achieves an advantage in drug discovery by leveraging its leading structural biology capabilities to determine the three dimensional structures of drug targets ahead of competitors and then uses these structures to efficiently create best-in-class drug candidates to treat diabetes, cancer, and other important diseases.
'/>"/>

SOURCE Takeda Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. CEO Wilson Defines GEs Health-IT Customer
2. Bruce Maas named CIO at UW-Milwaukee
3. Three finalists named for UW-Madison CIO
4. Eight lawmakers named to Speakers IT task force
5. Hospital named for Madame Curie installs TomoTherapy system
6. Two UW-Madison professors named to National LambdaRail Networking Research Council
7. UW researcher named top innovator
8. Alzheimers drug firm and more winners named in Wisconsin business-plan contest
9. Inacom named Microsofts favorite learning solutions partner of the year
10. Five Wisconsin CIOs named top in nation
11. Deltanoid named to top-15 list of biotech companies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...,, DURHAM,N.C.,Nov.25/PRNewswire/--ResearchT...efficient,single-treatmentwaterpurificationsystemN...desh,MinisterofRuralWaterSupply,Hon.MinisterViswar...ts,performedatIndianInstituteofTechnology(IIT)Kanp...ableinIndiacontainstoxinsthatcanbeextremelyhazardo...
(Date:11/25/2009)...,, BEIJING,Nov.25/PRNewswire-Asia/--SinovacB...cines,announcedtodaythatitexecuted,ajointventure(J...ologyCo.,Ltd.(SinovacDalian).TheJVwillresearch,dev...ovacwillcontributeitsexpertise,andexperienceindeve...herpartywillbringitslanduserights,manufacturingfac...
(Date:11/24/2009)..., Ambassador to also Visi...ber 24, 2009 -- , , ,Who: David Appia, French Amba...and CEO of the Invest in France Agency, , , , ,Wh...ss to discuss recent pro-business initiatives adop...scal and academic landscape for innovation and dev...
(Date:11/24/2009)...,, ST.LOUIS,Nov.24/PRNewswire-FirstCall/--Si...ingattheNASDAQOMXconferenceonTuesday,December1stat...ylistenvialiveaudiobroadcastovertheInternetavailab.../ .Userscanclickthe"Webcast"icontoaccessthisfile....ingLifeScienceandHighTechnologycompany.Itschemical...
Breaking Biology Technology:North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3
...ion a year for 10 years in tax credits , ,MADISON...Wisconsin was discussed at an economic development...day by the UW-Madison Small Business Development C...sting of investment specialists, from both the pub... of new tax-credit legislation, Act 255. , ,State ...
...Inc. and Bruker AXS have announced they will wo...tion and imaging products. , ,Crystal Farm, develo...nd Discovery Partners International , is an integ...n crystals, a process that helps companies design ...Rock Maker, a software package that automates and ...
...hree-part series focusing on the past, present and...s and serves as a follow up to WTNs interview wit..., WTN: During the next six to 12 months, what Dept...ssed or enacted? , , Cory Nettles: I had a meeti...talked about the Dept. of Commerces activities: wh...
Other Biology Technology:The impact of ACT 255 on the future of high-tech investment in Wisconsin 2Protein-crystal companies join forces for better imaging process 2WTN exclusive interview with Commerce Secretary Cory Nettles (part 2) 2WTN exclusive interview with Commerce Secretary Cory Nettles (part 2) 3WTN exclusive interview with Commerce Secretary Cory Nettles (part 2) 4WTN exclusive interview with Commerce Secretary Cory Nettles (part 2) 5
(Date:11/25/2009)...ed in the stomach, may be used to boost resistance...se, Yale School of Medicine researchers report in ...l of Neuroscience . , Parkinson,s disease is cau...ea of the midbrain known as the substantia nigra, ...uced production of dopamine in late-stage Parkinso...
(Date:11/25/2009)...time, the heart pumps some 250 million liters of b...e muscle fibers of the heart have to be extremely ... Rottbauer, vice chair of the Department of Medici...: Prof. Dr. H. A. Katus), has discovered a protein...lest muscular unit, the sarcomere. In cooperation ...
(Date:11/24/2009)... new doors to understanding how sounds associated ...ne mammal or if they hear it at all. , The same...t NASA uses to detect flaws in the space shuttle,s...tists to peek inside the giant head of a whale. Th...eplicas of a whale,s hearing anatomy using a break...
Breaking Biology News(10 mins):Hormone ghrelin can boost resistance to Parkinson's disease 2New genetic cause of cardiac failure discovered 2Rocket science leads to new whale discovery 2VIVUS Announces Positive Results From Two Phase 3 Studies 3B Obese Patients on Qnexa Achieve Average Weight Loss up to 14 7 25 and Significant Improve 13923 1VIVUS Announces Positive Results From Two Phase 3 Studies 3B Obese Patients on Qnexa Achieve Average Weight Loss up to 14 7 25 and Significant Improve 13923 2VIVUS Announces Positive Results From Two Phase 3 Studies 3B Obese Patients on Qnexa Achieve Average Weight Loss up to 14 7 25 and Significant Improve 13923 3VIVUS Announces Positive Results From Two Phase 3 Studies 3B Obese Patients on Qnexa Achieve Average Weight Loss up to 14 7 25 and Significant Improve 13923 4VIVUS Announces Positive Results From Two Phase 3 Studies 3B Obese Patients on Qnexa Achieve Average Weight Loss up to 14 7 25 and Significant Improve 13923 5VIVUS Announces Positive Results From Two Phase 3 Studies 3B Obese Patients on Qnexa Achieve Average Weight Loss up to 14 7 25 and Significant Improve 13923 6VIVUS Announces Positive Results From Two Phase 3 Studies 3B Obese Patients on Qnexa Achieve Average Weight Loss up to 14 7 25 and Significant Improve 13923 7VIVUS Announces Positive Results From Two Phase 3 Studies 3B Obese Patients on Qnexa Achieve Average Weight Loss up to 14 7 25 and Significant Improve 13923 8VIVUS Announces Positive Results From Two Phase 3 Studies 3B Obese Patients on Qnexa Achieve Average Weight Loss up to 14 7 25 and Significant Improve 13923 9Clinical Therapeutics Announces the Addition of Michael G Spigarelli MD PhD as Editor for a Refocused Pediatric Adolescent 26 Maternal Therapeu 13922 1Clinical Therapeutics Announces the Addition of Michael G Spigarelli MD PhD as Editor for a Refocused Pediatric Adolescent 26 Maternal Therapeu 13922 2Ben Shaker Joins Navvis 26amp 3B Company 56514 1Ben Shaker Joins Navvis 26amp 3B Company 56514 2
...New Belgian passport introduces technological brea...covert data -, LAKE WORTH, Fla., March 24 Graphi...erthur (FCO) have teamed to produce the,world,s fi...d in the new,Belgian passport released on February... produces the Belgian passport,has added an optica...
... Male infants in developed nations are more likely...lly responsible for mens shorter lifespans, reveal...nnsylvania and University of Southern California. ...e Monday, March 24 edition of the Proceedings of t...ries spanning three continents and hundreds of yea...
... Washington A policy monograph highlighting the n...mination in employment and insurance practices was...ans (ACP). The six policy positions ACP believes ...the focus of the policy paper. http://www.acponli... , While theyre not quite there, Congress does ...
Other Biology News:FCO and GSSC Team to Create World's First Self-Authenticating Passport 2Baby boys are more likely to die than baby girls 2Need for federal protection against genetic discrimination 2
Human Granulocyte Macrophage Colony Stimulating Factor, Unconjugated from PeproTech
...udes: Sufficient library for 10 separate biopannin...quences, -28 gIII Sequencing Primer (100 pmol), fo...r (100 pmol), for automated DNA sequencing, Host E...) and Elutant (Biotin), Detailed protocols for sur...
ReBlot Western Blot Recycling Kit - Trial from CHEMICON
ELISA Strips from Santa Cruz Biotechnology, Inc.
Biology Products: